AdAlta CEO Sam Cobb was recently profiled by Fairfax media, discussing the success story of CSL as an inspiration for AdAlta to follow in its footsteps. Click here to read the article published in the Sydney Morning Herald titled ‘Watch out CSL, here we come’: biotech gears to go global.
“My vision for AdAlta is that we become a bigger company … [with] drug discovery that’s competitive on a world scale.”